Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mattia Falchetto Osti

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Radiation Oncology (London, England)|October 13, 2016
Target delineation and optimal radiosurgical dose for pituitary tumorsGiuseppe Minniti, Mattia Falchetto Osti, Maximillian Niyazi
World Journal of Gastroenterology|January 27, 2016
Adjuvant radiochemotherapy for gastric cancer: Should we use prognostic factors to select patients?Linda Agolli, Riccardo Maurizi Enrici, Mattia Falchetto Osti
Radiation Oncology (London, England)|June 21, 2017
Radiation therapy for older patients with brain tumorsGiuseppe Minniti, Andrea Riccardo Filippi, Mattia Falchetto Osti, et al.
Expert Review of Anticancer Therapy|March 12, 2017
Critical decision-making in radiotherapy for early stage breast cancer in a neo-adjuvant treatment eraFrancesca De Felice, Mattia Falchetto Osti, Vitaliana De Sanctis, et al.
Anticancer Research|March 31, 2018
Interventions to Reduce Neurological Symptoms in Patients with GBM Receiving Radiotherapy: From Theory to Clinical PracticeLucia Palombi, Paolo Marchetti, Maurizio Salvati, et al.
Clinical Colorectal Cancer|August 15, 2016
Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long-Term Follow-UpLinda Agolli, Stefano Bracci, Luca Nicosia, et al.
Radiation Oncology (London, England)|September 28, 2014
Image guided intensity modulated hypofractionated radiotherapy in high-risk prostate cancer patients treated four or five times per week: analysis of toxicity and preliminary resultsMaurizio Valeriani, Alessia Carnevale, Mattia Falchetto Osti, et al.
Cancer Treatment and Research Communications|October 26, 2021
Stereotactic body radiation therapy (SBRT) for patients with oligometastatic/oligoprogressive adrenal metastases: Outcomes and toxicities profile in a monoinstitutional studyGiuseppe Facondo, Gianluca Vullo, Maurizio Valeriani, et al.
Tumori|February 8, 2013
A case report of metastatic atypical thymic carcinoid with ectopic ACTH production: locoregional control after adaptive radiation treatmentMaurizio Valeriani, Linda Agolli, Teresa Falco, et al.
Anticancer Research|October 4, 2011
Hypofractionated radiotherapy with or without IGRT in prostate cancer: preliminary report of acute toxicityMaurizio Valeriani, Flavia Monaco, Mattia Falchetto Osti, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Radiation Oncology (London, England)|October 13, 2016
Target delineation and optimal radiosurgical dose for pituitary tumorsGiuseppe Minniti, Mattia Falchetto Osti, Maximillian Niyazi
World Journal of Gastroenterology|January 27, 2016
Adjuvant radiochemotherapy for gastric cancer: Should we use prognostic factors to select patients?Linda Agolli, Riccardo Maurizi Enrici, Mattia Falchetto Osti
Radiation Oncology (London, England)|June 21, 2017
Radiation therapy for older patients with brain tumorsGiuseppe Minniti, Andrea Riccardo Filippi, Mattia Falchetto Osti, et al.
Expert Review of Anticancer Therapy|March 12, 2017
Critical decision-making in radiotherapy for early stage breast cancer in a neo-adjuvant treatment eraFrancesca De Felice, Mattia Falchetto Osti, Vitaliana De Sanctis, et al.
Anticancer Research|March 31, 2018
Interventions to Reduce Neurological Symptoms in Patients with GBM Receiving Radiotherapy: From Theory to Clinical PracticeLucia Palombi, Paolo Marchetti, Maurizio Salvati, et al.
Clinical Colorectal Cancer|August 15, 2016
Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long-Term Follow-UpLinda Agolli, Stefano Bracci, Luca Nicosia, et al.
Radiation Oncology (London, England)|September 28, 2014
Image guided intensity modulated hypofractionated radiotherapy in high-risk prostate cancer patients treated four or five times per week: analysis of toxicity and preliminary resultsMaurizio Valeriani, Alessia Carnevale, Mattia Falchetto Osti, et al.
Cancer Treatment and Research Communications|October 26, 2021
Stereotactic body radiation therapy (SBRT) for patients with oligometastatic/oligoprogressive adrenal metastases: Outcomes and toxicities profile in a monoinstitutional studyGiuseppe Facondo, Gianluca Vullo, Maurizio Valeriani, et al.
Tumori|February 8, 2013
A case report of metastatic atypical thymic carcinoid with ectopic ACTH production: locoregional control after adaptive radiation treatmentMaurizio Valeriani, Linda Agolli, Teresa Falco, et al.
Anticancer Research|October 4, 2011
Hypofractionated radiotherapy with or without IGRT in prostate cancer: preliminary report of acute toxicityMaurizio Valeriani, Flavia Monaco, Mattia Falchetto Osti, et al.
Pageof 8